ErlySign - Total Funding, Funding Over Time, Funding By Rounds and More
Founded in 2019, ErlySign operates in Health Tech industry. Initially concentrating on easy-to-use cancer detection diagnostics, the company has expanded its focus to include a broader array of biotec...
Funding stage:
Pre-Series A
Last funding:
14/01/2025
Total funding:
$2.00 Mn+
Revenue:
Investors
Employee count:
14
Last 90d
14
Last 90d
ErlySign: Funding Highlights
Funding highlights of ErlySign and a snapshot of its key metrics.
Total Funding$2.00 Mn+
Current StageGrowth Stage
Total Round(s)2
Funding Rounds
FAQs on Funding of ErlySign
Health Tech Funded ErlySign has raised a total funding of $2.00 million as of 15 January 2025 across 2 rounds. Find the details around funding rounds, participating investors, and other insights of ErlySign here...
ErlySign has raised a total of $2.00 million across 2 funding rounds and the last round was raised on 15 January 2025.
ErlySign's key investors include Ashish Kacholia, LetsVenture, and Rajesh Manthena.
ErlySign's latest funding round was $1.80 million in Growth Stage, raised on 15 January 2025.
ErlySign is at the Growth stage. Its most recent round was raised on 15 January 2025.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links